IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells.
about
Novel enriched pathways in superficial malignant peripheral nerve sheath tumours and spindle/desmoplastic melanomas.The role of NFκB in spheroid formation of human breast cancer cells cultured on the Random Positioning Machine.Network integration of multi-tumour omics data suggests novel targeting strategiesProteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapyUpregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling
P2860
IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IKKβ inhibitor in combination ...... xicity in breast cancer cells.
@en
IKKβ inhibitor in combination ...... xicity in breast cancer cells.
@nl
type
label
IKKβ inhibitor in combination ...... xicity in breast cancer cells.
@en
IKKβ inhibitor in combination ...... xicity in breast cancer cells.
@nl
prefLabel
IKKβ inhibitor in combination ...... xicity in breast cancer cells.
@en
IKKβ inhibitor in combination ...... xicity in breast cancer cells.
@nl
P2093
P2860
P356
P1476
IKKβ inhibitor in combination ...... xicity in breast cancer cells.
@en
P2093
Akinori Iwasaki
Hiromasa Hideshima
Hiroshi Ikeda
Teru Hideshima
Yasuhiro Yoshida
P2860
P304
P356
10.3892/IJO.2014.2273
P577
2014-01-23T00:00:00Z